TY  - BOOK
AU  - Barac, Ana
AU  - Zaghlol, Raja
TI  - The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States
SN  - 0886-0440
PY  - 2020///
KW  - *Hospital Mortality
KW  - *Mechanical Thrombolysis/ae [Adverse Effects]
KW  - *Mechanical Thrombolysis/mt [Methods]
KW  - *Neoplasms/co [Complications]
KW  - *Patient Readmission/sn [Statistics & Numerical Data]
KW  - *Venous Thromboembolism/mo [Mortality]
KW  - *Venous Thromboembolism/th [Therapy]
KW  - Catheters
KW  - Cohort Studies
KW  - Costs and Cost Analysis
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - United States/ep [Epidemiology]
KW  - Venous Thromboembolism/ec [Economics]
KW  - MedStar Heart & Vascular Institutena
KW  - MedStar Washington Hospital Center
KW  - Medicine/Internal Medicine
KW  - Journal Article
N2  - BACKGROUND: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure; CONCLUSION: The use of CDL does not appear to reduce the risk of returning for a VTE-related admission in cancer. Copyright (c) 2020 Wiley Periodicals, Inc; METHODS: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states); RESULTS: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P < .0001). Additionally, in-hospital mortality (5.7% vs 1.1%; P = 0.009) and cost-of-care (
UR  - https://dx.doi.org/10.1111/jocs.14444
ER  -